TriSalus Life Sciences (TLSI) Shares Outstanding (Diluted Average) (2020 - 2026)

TriSalus Life Sciences (TLSI) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $52.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 83.38% year-over-year to $52.3 million; the trailing twelve-month figure through Mar 2026 stood at $52.3 million (up 83.38% YoY), and the FY2025 full-year result was $37.9 million, up 49.61% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $52.3 million, up from $37.9 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $52.3 million in Q1 2026 and bottomed at $309609.0 in Q4 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $23.6 million (2024), against an average of $20.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) slumped 98.75%; it then jumped 5497.4% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $309609.0 in 2022, then jumped by 2934.71% to $9.4 million in 2023, then surged by 169.61% to $25.3 million in 2024, then surged by 49.61% to $37.9 million in 2025, then jumped by 38.04% to $52.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $52.3 million (Q1 2026), $37.9 million (Q4 2025), and $34.9 million (Q3 2025), per Business Quant data.

Peer Comparison